MyFinsight
Home
Blog
About
Short-term investments
$943,145K
(-0.04%↓ Y/Y)
Cash and cash
equivalents
$27,768K
(-47.05%↓ Y/Y)
Prepaid expenses and
other current assets
$12,275K
(28.64%↑ Y/Y)
Accounts receivable, net
$149K
Total property and
equipment
$11,075K
(3.50%↑ Y/Y)
Total current assets
$983,337K
(-2.21%↓ Y/Y)
Operating lease
right-of-use assets
$17,327K
(-6.15%↓ Y/Y)
Property and equipment,
net
$3,260K
(-30.46%↓ Y/Y)
Other long-term
assets
$2,913K
(8.17%↑ Y/Y)
Restricted cash
$816K
(0.00%↑ Y/Y)
Less accumulated
depreciation
$7,815K
(29.99%↑ Y/Y)
Total assets
$1,007,653K
(-2.38%↓ Y/Y)
Total liabilities and
stockholders' equity
$1,007,653K
(-2.38%↓ Y/Y)
Total stockholders'
equity
$927,984K
(-6.31%↓ Y/Y)
Total liabilities
$79,669K
(91.07%↑ Y/Y)
Accumulated deficit
-$397,715K
(-34.76%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$2,305K
(-161.52%↓ Y/Y)
Additional paid-in capital
$1,327,943K
(3.60%↑ Y/Y)
Total current
liabilities
$60,152K
(181.36%↑ Y/Y)
Operating lease
liabilities, net of current...
$18,438K
(-9.25%↓ Y/Y)
Deferred revenue, net of
current portion
$1,079K
Common stock, 0.001 par
value authorized...
$61K
(3.39%↑ Y/Y)
Current portion of
deferred revenue
$35,070K
Accrued expenses
$19,513K
(21.74%↑ Y/Y)
Accounts payable
$3,017K
(-13.23%↓ Y/Y)
Current portion of
operating lease...
$2,552K
(36.25%↑ Y/Y)
Back
Back
Balance Sheet
Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX)
source: myfinsight.com